Skip to main content
    M

    Medical Properties Trust, Inc. (MPT)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $1.49
    -0.18 (-11.08%)

    Market Cap: $983.46M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Medical Properties Trust, Inc. (MPT) Earnings: Report Dates and Results

    Updated Oct 29, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    FFO per share for Medical Properties Trust (MPT) was $0.52 for 2025. In the quarter ended Sep 30, 2026, Medical Properties Trust reported EPS of $0.11, below the $0.13 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate. Medical Properties Trust is expected to report earnings on Feb 17, 2027.

    Earnings

    Performance (10Y)

    Beat Rate
    16%(6/37)
    Avg Surprise
    -55.87%

    Upcoming Estimates

    Reports Feb 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.02
    Range-$0.05 - $0.07
    6 analysts
    Revenue Consensus
    $248.57M
    Range$221.68M - $276.94M
    8 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.01
    Range-$0.03 - $0.01
    2 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.04-125.0%
    60d ago$0.03-133.3%
    30d ago$0.02-166.7%
    7d ago$0.02-166.7%
    Current-$0.01
    Revenue Consensus
    $258.71M
    Range$250.14M - $267.29M
    2 analysts

    Next Report

    MPT has an expected report date of Feb 17, 2027.

    MPT Earnings Call

    The latest MPT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 37 quarters below that had an estimate, MPT beat 6, missed 25 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $250.14M, up 5.3% from $237.52M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.11$0.13N/A-15.38%MissN/A10 up, 0 downOct 29, 2026$250.14M
    Jun 30, 2026$0.15$0.16N/A-6.25%MissN/A10 up, 1 downAug 10, 2026$259.28M
    Mar 31, 2026$0.09$0.01$0.00 - $0.01+800.00%BeatN/A20 up, 1 downApr 30, 2026$252.06M
    Dec 31, 2025$0.03$0.02N/A+50.00%BeatN/AN/AN/AFeb 19, 2026$270.34M
    Sep 30, 2025-$0.13$0.02N/A-750.00%MissN/AN/AN/AOct 30, 2025$237.52M
    Jun 30, 2025-$0.16$0.02N/A-900.00%Miss-500.0%N/AN/AJul 31, 2025$240.36M
    Mar 31, 2025-$0.20-$0.01N/AN/AN/AN/AN/AN/AMay 1, 2025$223.80M
    Dec 31, 2024-$0.69-$0.06N/AN/AN/AN/AN/AN/AFeb 27, 2025$235.27M
    Sep 30, 2024-$0.09$0.10N/A-190.00%Miss-145.0%N/AN/ANov 7, 2024$225.83M
    Jun 30, 2024$0.04$0.10N/A-60.00%MissN/AN/AN/AAug 8, 2024$266.56M
    Mar 31, 2024-$0.07$0.11N/A-163.64%Miss-135.0%N/AN/AMay 9, 2024$271.32M
    Dec 31, 2023-$0.63$0.16N/A-493.75%MissN/AN/AN/AFeb 21, 2024N/A
    Sep 30, 2023$0.20$0.19N/A+5.26%Beat-23.1%N/AN/AOct 26, 2023$306.58M
    Jun 30, 2023-$0.07$0.20N/A-135.00%Miss-124.1%N/AN/AAug 8, 2023$349.62M
    Mar 31, 2023$0.20$0.22N/A-9.09%Miss-33.3%N/AN/AApr 27, 2023$361.56M
    Dec 31, 2022-$0.24N/AN/AN/AN/A-187.3%N/AN/AFeb 23, 2023$387.68M
    Sep 30, 2022$0.26$0.30N/A-13.33%Miss-3.7%N/AN/AOct 27, 2022$363.82M
    Jun 30, 2022$0.29$0.31N/A-6.45%Miss+45.0%N/AN/AAug 3, 2022$415.01M
    Mar 31, 2022$0.30$0.32N/A-6.25%Miss+7.1%N/AN/AApr 28, 2022$417.14M
    Dec 31, 2021$0.27$0.32N/A-15.63%Miss+35.0%N/AN/AFeb 3, 2022$416.19M
    Sep 30, 2021$0.27$0.29N/A-6.90%Miss+8.0%N/AN/AOct 28, 2021$397.97M
    Jun 30, 2021$0.20$0.30N/A-33.33%Miss-4.8%N/AN/AJul 29, 2021$389.13M
    Mar 31, 2021$0.28$0.25N/A+12.00%Beat+47.4%N/AN/AApr 29, 2021$369.87M
    Dec 31, 2020$0.20$0.28N/A-28.57%Miss-9.1%N/AN/AFeb 4, 2021$338.96M
    Sep 30, 2020$0.25$0.26N/A-3.85%Miss+25.0%N/AN/AOct 29, 2020$335.35M
    Jun 30, 2020$0.21$0.25N/A-16.00%Miss+5.0%N/AN/AJul 30, 2020$297.13M
    Mar 31, 2020$0.19$0.30N/A-36.67%Miss-5.0%N/AN/AApr 29, 2020$298.21M
    Dec 31, 2019$0.22$0.22N/A0.00%In line0.0%N/AN/AFeb 6, 2020$260.85M
    Sep 30, 2019$0.20$0.20N/A0.00%In line-20.0%N/AN/AOct 31, 2019$224.76M
    Jun 30, 2019$0.20$0.19N/A+5.26%Beat-16.7%N/AN/AAug 1, 2019$192.55M
    Mar 31, 2019$0.20$0.22N/A-9.09%Miss-20.0%N/AN/AMay 2, 2019$180.45M
    Dec 31, 2018$0.22$0.22N/A0.00%In line-4.3%N/AN/AFeb 7, 2019$180.58M
    Sep 30, 2018$0.25$0.25N/A0.00%In line+19.0%N/AN/ANov 1, 2018$197.00M
    Jun 30, 2018$0.24$0.26N/A-7.69%Miss+14.3%N/AN/AAug 2, 2018$201.90M
    Mar 31, 2018$0.25$0.27N/A-7.41%Miss+4.2%N/AN/AMay 3, 2018$205.05M
    Dec 31, 2017$0.23$0.23N/A0.00%In line+76.9%N/AN/AFeb 8, 2018$204.96M
    Sep 30, 2017$0.21$0.22N/A-4.55%Miss+5.0%N/AN/ANov 2, 2017$176.58M
    Jun 30, 2017$0.21$0.21N/A0.00%In line-19.2%N/AN/AAug 9, 2017$166.81M
    Mar 31, 2017$0.24$0.21N/A+14.29%Beat0.0%N/AN/AMay 4, 2017$156.40M
    Dec 31, 2016$0.13$0.20N/A-35.00%Miss-50.0%N/AN/AFeb 9, 2017$153.28M
    Last 40 quarters

    Annual FFO

    FFO per share was $0.52 for 2025, down 10.3% from $0.58 in 2024. It was $1.26 for 2016, the oldest of the 10 years shown.

    Fiscal yearFFO per shareChange
    2025$0.52-10.3%
    2024$0.58-68.1%
    2023$1.82+4.0%
    2022$1.75+11.5%
    2021$1.57+20.8%
    2020$1.30-5.1%
    2019$1.37+1.5%
    2018$1.35+5.5%
    2017$1.28+1.6%
    2016$1.26N/A

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.46, after -$0.81 the year before. It was $0.83 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.46N/A
    Dec 31, 2024-$0.81N/A
    Dec 31, 2023-$0.30-148.8%
    Dec 31, 2022$0.61-39.8%
    Dec 31, 2021$1.02+20.0%
    Dec 31, 2020$0.85N/A
    Dec 31, 2019$0.82-14.6%
    Dec 31, 2018$0.96+7.9%
    Dec 31, 2017$0.89+7.2%
    Dec 31, 2016$0.83N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,400 words across 9 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20263,4339
    2026Q2Jun 30, 20264,54912
    2025Q4Dec 31, 20254,53413
    2025Q3Sep 30, 20254,01710
    2025Q2Jun 30, 20254,60211
    2025Q1Mar 31, 20254,94410
    2024Q4Dec 31, 20245,90813
    2024Q3Sep 30, 20243,8989

    2026Q3 Earnings Call

    Opening remarks

    Charles Lambert Senior Vice President Good morning. Welcome to the MPT conference call to discuss our third quarter 2026 financial results. With me today are Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer of the company; Steven Hamner, Executive Vice President and Chief Financial Officer; Kevin Hanna, Senior Vice President, Controller and Chief Accounting Officer; Rosa Williams, Senior Vice President of Operations and Secretary; and Jason Frey, Managing Director, Asset Management and Underwriting. Our press release was distributed this morning and furnished on Form 8-K with the Securities and Exchange Commission. If you did not receive a copy, it is available on our website at mpt.com in the Investor Relations section. Additionally, we're hosting a live webcast of today's call, which you can access in that same section. During the course of this call, we will make projections and certain other statements that may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our financial results and future events to differ materially from those expressed in or underlying such forward-looking statements. We refer you to the company's reports filed with the Securities and Exchange Commission for a discussion of the factors that could cause the company's actual results or future events to differ materially from those expressed in this call. The information being provided today is as of this date only, and except as required by the federal securities laws, the company does not undertake a duty to update any such information. In addition, during the course of the conference call, we will describe certain non-GAAP financial measures, which should be considered in addition to and not in lieu of comparable GAAP financial measures. Please note that in our press release, MPT has reconciled all non-GAAP financial measures to the most directly comparable GAAP measures in accordance with Regulation G requirements. You can also refer to our website at mpt.com for the most directly comparable financial measures and related reconciliations. I will now turn the call over to our Chief Executive Officer, Ed Aldag.

    Edward Aldag Chairman, President and Chief Executive Officer Thank you, Charles, and thank all of you for joining us this morning. Earlier this year, we projected MPT would reach annualized cash rental revenue of at least $1 billion by the end of this year. Year-to-date, we have already collected more than $750 million of cash revenue, which annualizes to more than the $1 billion we projected earlier. This reflects the strength of our diverse portfolio of operators around the world. During the year, we've sold 9 properties for cash proceeds of approximately $600 million, and we still hit our target.

    Frequently Asked Questions About MPT

    When is Medical Properties Trust's next earnings date?

    Medical Properties Trust's next earnings report is expected for Feb 17, 2027.

    Did MPT beat earnings estimates last quarter?

    No. Medical Properties Trust reported EPS of $0.11 for the quarter ended Sep 30, 2026, below the $0.13 estimate by 15.38%.

    What EPS do analysts expect from MPT next quarter?

    The consensus EPS estimate for Medical Properties Trust for the quarter ending Dec 31, 2026 is -$0.02 from 6 analysts, with estimates from -$0.05 to $0.07.

    How often does MPT beat earnings estimates?

    Medical Properties Trust beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -133.95%.